Answer
Aldactone (spironolactone) is licensed for congestive cardiac failure, hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, and diagnosis and treatment of primary aldosteronism; children should only be treated under a paediatric specialist’s guidance, as paediatric data are limited.
Sources for this answer
- Aldactone 25mg TabletsPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 22Document updated
Sources checked